The latest Thermo Scientific BioPharma Finder 4.0 software, for scientists in the development of new biopharmaceuticals, introduces an advanced solution for the characterisation of both protein biotherapeutics and oligonucleotide therapeutics, providing enhanced flexibility to biopharmaceutical laboratories. Using a novel MS2 prediction algorithm, automatic identification and annotation using MS2 data, the software offers increased confidence in results with reduced operator effort. The updated Sequence Manager supports DNA and RNA and allows users to create their own oligo sequences for a new level of adaptability for a wide range of study.